Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ralph

Showing results (161-170 of 302) with videos related to

Pageof 31
Sort By:
Journal of the American Heart Association|December 19, 2018
How Many Doses Make a Difference? An Analysis of Secondary Prevention of Rheumatic Fever and Rheumatic Heart DiseaseJessica Langloh de Dassel, Nick de Klerk, Jonathan Rhys Carapetis, et al.
Cancer Research|November 1, 1979
Matching of chemotherapy to mouse strain and lymphoid tumor type to prevent tumor-induced suppression of specific T- and B-cell functionsR B Faanes, V J Merluzzi, N Williams, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1979
Induction of prostaglandin E synthesis in normal and neoplastic macrophages: role for colony-stimulating factor(s) distinct from effects on myeloid progenitor cell proliferationJ I Kurland, L M Pelus, P Ralph, et al.
The Pediatric Infectious Disease Journal|September 27, 2018
Streptococcal Serology in Acute Rheumatic Fever Patients: Findings From 2 High-income, High-burden SettingsSusan Jack, Nicole J Moreland, Jess Meagher, et al.
The Medical Journal of Malaysia|August 8, 2015
Individualised second line anti-tuberculous therapy for an extensively resistant pulmonary tuberculosis (XDR PTB) in East MalaysiaS R A Muhammad Redzwan, A P Ralph, K K Sivaraman Kannan, et al.
Cancer Research|July 1, 1985
Distinct differentiation-inducing activities of gamma-interferon and cytokine factors acting on the human promyelocytic leukemia cell line HL-60P E Harris, P Ralph, J Gabrilove, et al.
Kekkaku : [Tuberculosis]|November 1, 1980
Enhancement of macrophage cytotoxicity to tumors and production of megakaryocyte-stimulating factors by microbial agentsP Ralph, N Williams, I Nakoinz, et al.
Australian Journal of General Practice|December 1, 2022
Improving primary care for Aboriginal and Torres Strait Islander people with rheumatic heart disease: What can I do?Rosemary Wyber, Anna P Ralph, Asha C Bowen, et al.
Journal of Immunological Methods|March 28, 1997
A non-radioactive complement-dependent cytotoxicity assay for anti-CD20 monoclonal antibodyH Gazzano-Santoro, P Ralph, T C Ryskamp, et al.
Australian and New Zealand Journal of Public Health|November 24, 2017
Aboriginal children and penicillin injections for rheumatic fever: how much of a problem is injection pain?Alice G Mitchell, Suzanne Belton, Vanessa Johnston, et al.
Pageof 31

Showing results (161-170 of 302) with videos related to

Sort By:
Pageof 31
Journal of the American Heart Association|December 19, 2018
How Many Doses Make a Difference? An Analysis of Secondary Prevention of Rheumatic Fever and Rheumatic Heart DiseaseJessica Langloh de Dassel, Nick de Klerk, Jonathan Rhys Carapetis, et al.
Cancer Research|November 1, 1979
Matching of chemotherapy to mouse strain and lymphoid tumor type to prevent tumor-induced suppression of specific T- and B-cell functionsR B Faanes, V J Merluzzi, N Williams, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1979
Induction of prostaglandin E synthesis in normal and neoplastic macrophages: role for colony-stimulating factor(s) distinct from effects on myeloid progenitor cell proliferationJ I Kurland, L M Pelus, P Ralph, et al.
The Pediatric Infectious Disease Journal|September 27, 2018
Streptococcal Serology in Acute Rheumatic Fever Patients: Findings From 2 High-income, High-burden SettingsSusan Jack, Nicole J Moreland, Jess Meagher, et al.
The Medical Journal of Malaysia|August 8, 2015
Individualised second line anti-tuberculous therapy for an extensively resistant pulmonary tuberculosis (XDR PTB) in East MalaysiaS R A Muhammad Redzwan, A P Ralph, K K Sivaraman Kannan, et al.
Cancer Research|July 1, 1985
Distinct differentiation-inducing activities of gamma-interferon and cytokine factors acting on the human promyelocytic leukemia cell line HL-60P E Harris, P Ralph, J Gabrilove, et al.
Kekkaku : [Tuberculosis]|November 1, 1980
Enhancement of macrophage cytotoxicity to tumors and production of megakaryocyte-stimulating factors by microbial agentsP Ralph, N Williams, I Nakoinz, et al.
Australian Journal of General Practice|December 1, 2022
Improving primary care for Aboriginal and Torres Strait Islander people with rheumatic heart disease: What can I do?Rosemary Wyber, Anna P Ralph, Asha C Bowen, et al.
Journal of Immunological Methods|March 28, 1997
A non-radioactive complement-dependent cytotoxicity assay for anti-CD20 monoclonal antibodyH Gazzano-Santoro, P Ralph, T C Ryskamp, et al.
Australian and New Zealand Journal of Public Health|November 24, 2017
Aboriginal children and penicillin injections for rheumatic fever: how much of a problem is injection pain?Alice G Mitchell, Suzanne Belton, Vanessa Johnston, et al.
Pageof 31